Hyperfine Expands Revolution: Optive AI™ Approved in the EU and UK

by Upcare Team | Sep 4, 2025 | Hyperfine

AI-Powered Swoop® Portable MRI Receives CE Mark and UKCA Approval, Delivering Unprecedented Image Quality to European Markets. Hyperfine, our partner at the forefront of brain imaging innovation, has obtained CE Marking and UK Conformity Assessment (UKCA) approval for...

Beyond a Product: KyphoLift is a Mission to Elevate Patient Positioning

by Upcare Team | Aug 21, 2025 | Kypholift

A deeply personal story and a wealth of clinical experience drive an innovative solution for imaging technologists and patients The story behind KyphoLift, our partner’s groundbreaking patient positioning system, is rooted in the very challenges it was designed...

Hyperfine’s Swoop® System Achieves 100% Sensitivity for ARIA-E Detection in New Alzheimer’s Study

by Upcare Team | Jul 28, 2025 | Hyperfine

Promising Data from CARE PMR Study Presented at AAIC 2025 Highlights Portable MRI as a Game-Changer for Point-of-Care Monitoring New interim results presented by our partner Hyperfine at the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto are...

Hyperfine’s Optive AI™ Software Elevates Portable MRI Imaging

by Upcare Team | Jun 2, 2025 | Hyperfine

Hyperfine launches Optive AI™ software in the U.S. and Canada, delivering a transformative leap in image quality for existing Swoop® portable MRI systems through advanced AI. Hyperfine has officially launched its Optive AI™ software for existing Swoop® Portable MR...

Optive AI™: Hyperfine’s 10th-Gen Software Gets FDA Green Light

by Upcare Team | May 30, 2025 | Hyperfine

A quantum leap in portable brain imaging, powered by AI Hyperfine has officially announced FDA clearance for Optive AI™, its next-generation imaging software and the 10th major release for the Swoop® Portable MR Imaging System. This milestone marks a major advancement...